What is Pharmaron?
Pharmaron operates across the entire spectrum of drug development, offering a wide array of services that span from initial discovery through to manufacturing. The company's expertise encompasses small molecule drugs, advanced cell therapies, and cutting-edge gene therapies. Furthermore, Pharmaron provides critical testing services for medical devices and supports clinical research operations. This integrated approach allows Pharmaron to serve a diverse clientele within the life sciences industry, facilitating the progression of novel therapeutics from concept to market.
How much funding has Pharmaron raised?
Pharmaron has raised a total of $342.8M across 3 funding rounds:
Series B
$22.8M
Series C
$40M
Unspecified
$280M
Series B (2008): $22.8M with participation from Legend Capital, Avenue Capital Group, and DCM Ventures
Series C (2011): $40M led by GL Capital Group, DCM Ventures, and Legend Capital
Unspecified (2015): $280M supported by Legend Capital
Key Investors in Pharmaron
Legend Capital
Legend Capital is a prominent private equity fund manager with a significant track record, focusing on innovation and growth enterprises, particularly those with operations in or related to China. Their extensive investment history suggests a strategic approach to backing companies with strong market potential.
GL Capital Group
GL Capital Group is an investment firm that likely focuses on strategic capital allocation within the healthcare and technology sectors, given its participation in Pharmaron's Series C funding.
DCM Ventures
DCM Ventures is a venture capital firm known for investing in early-stage technology and healthcare companies. Their involvement indicates a belief in Pharmaron's innovative approach and growth potential.
What's next for Pharmaron?
The recent major strategic investment in Pharmaron signals a strong confidence from its backers in the company's future trajectory. This capital infusion is expected to fuel further expansion of its research and development initiatives, potentially leading to advancements in its therapeutic pipelines and manufacturing capacities. As Pharmaron continues to scale its operations, it is poised to solidify its role as a key partner for pharmaceutical and biotech firms seeking end-to-end solutions. The company's focus on innovation in drug discovery and development, coupled with its robust testing and manufacturing services, positions it for sustained growth and influence within the global healthcare landscape.
See full Pharmaron company page
